EX-99 3 a2065749zex-99.htm EX-99 Prepared by MERRILL CORPORATION
QuickLinks -- Click here to rapidly navigate through this document


Exhibit 99

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS(1)

(In thousands, except per share amounts)

 
  For the Quarter Ended
September 30,

  For the Year Ended
September 30,

 
 
  2000
  2001
  2000
  2001
 
Net revenue   $ 432,369   $ 432,562   $ 1,640,933   $ 1,755,512  
Costs and expenses:                          
  Salaries, cost of care and other operating expenses     378,506     391,495     1,442,082     1,557,042  
  Equity in earnings of unconsolidated subsidiaries     (945 )   (3,330 )   (9,792 )   (36,566 )
   
 
 
 
 
      377,561     388,165     1,432,290     1,520,476  
   
 
 
 
 
  EBITDA     54,808     44,397     208,643     235,036  
   
 
 
 
 
  Depreciation and amortization     17,371     18,035     68,261     68,294  
  Interest, net     25,085     22,742     97,286     93,662  
  Special charges, net     25,398         25,398     3,340  
   
 
 
 
 
      67,854     40,777     190,945     165,296  
   
 
 
 
 
Income (loss) from continuing operations before provision for (benefit from) income taxes and minority interest     (13,046 )   3,620     17,698     69,740  
Provision for (benefit from) income taxes     (11,133 )   3,024     8,994     36,388  
   
 
 
 
 
Income (loss) from continuing operations before minority interest     (1,913 )   596     8,704     33,352  
Minority interest     9     7     114     78  
   
 
 
 
 
Income (loss) from continuing operations     (1,922 )   589     8,590     33,274  
   
 
 
 
 
Income (loss) from discontinued operations (net of taxes)     (8,312 )   (1,010 )   (56,736 )   4,624  
Loss on disposal of discontinued operations     (17,662 )   37     (17,662 )   (9,359 )
   
 
 
 
 
      (25,974 )   (973 )   (74,398 )   (4,735 )
   
 
 
 
 
Income (loss) before extraordinary item     (27,896 )   (384 )   (65,808 )   28,539  
Extraordinary item — net (loss) on early extinguishment of debt                 (3,984 )
   
 
 
 
 
Net income (loss)     (27,896 )   (384 )   (65,808 )   24,555  
Preferred dividend requirement and amortization of redeemable preferred stock issuance costs     1,303     1,302     3,802     5,049  
   
 
 
 
 
Income (loss) available to common stockholders     (29,199 )   (1,686 )   (69,610 )   19,506  
   
 
 
 
 
Unrealized foreign currency translation gain (loss)     (59 )       (170 )   (113 )
Provision for (benefit from) income taxes related to unrealized foreign currency translation gain (loss)     24         68     45  
   
 
 
 
 
Other comprehensive income (loss)     (35 )       (102 )   (68 )
   
 
 
 
 
Comprehensive income (loss)   $ (29,234 ) $ (1,686 ) $ (69,712 ) $ 19,438  
   
 
 
 
 
                   
Average number of common shares outstanding — basic     32,368     34,535     32,144     33,448  
   
 
 
 
 
Average number of common shares outstanding — diluted     32,368     34,535     32,386     41,235  
   
 
 
 
 
Income (loss) per common share available for common stockholders — basic:                          
  Income (loss) from continuing operations   $ (0.10 ) $ (0.02 ) $ 0.15   $ 0.84  
   
 
 
 
 
  Income (loss) from discontinued operations   $ (0.80 ) $ (0.03 ) $ (2.32 ) $ (0.14 )
   
 
 
 
 
  Extraordinary (loss) on early extinguishment of debt   $   $   $   $ (0.12 )
   
 
 
 
 
Income (loss) available to common stockholders   $ (0.90 ) $ (0.05 ) $ (2.17 ) $ 0.58  
   
 
 
 
 
Income per common share available for common stockholders — diluted:                          
  Income (loss) from continuing operations   $ (0.10 ) $ (0.02 ) $ 0.15   $ 0.81  
   
 
 
 
 
  Income (loss) from discontinued operations   $ (0.80 ) $ (0.03 ) $ (2.30 ) $ (0.11 )
   
 
 
 
 
  Extraordinary (loss) on early extinguishment of debt   $   $   $   $ (0.10 )
   
 
 
 
 
Income (loss) available to common stockholders   $ (0.90 ) $ (0.05 ) $ (2.15 ) $ 0.60  
   
 
 
 
 

(1)
For a more detailed discussion of Magellan's fiscal 2001 results, please consult the Company's Annual Report on Form 10-K which will be filed with the SEC by December 29, 2001.

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

SUPPLEMENTAL FINANCIAL INFORMATION

(In thousands, except per share amounts)

 
  For the Quarter Ended
September 30,

  For the Year Ended
September 30,

 
 
  2000
  2001
  2000
  2001
 
INCOME FROM CONTINUING OPERATIONS — AS ADJUSTED(1)                          
Income (loss) from continuing operations before taxes   $ (13,046 ) $ 3,620   $ 17,698   $ 69,740  
TRICARE pricing settlements less incurred claims adjustments                 (28,018 )
Special charges     25,398         25,398     3,340  
Adjusted tax provision(2)     (7,691 )   (3,024 )   (28,238 )   (26,517 )
Minority interest     (9 )   (7 )   (114 )   (78 )
   
 
 
 
 
Adjusted income (loss) from continuing operations     4,652     589     14,744     18,467  
Preferred dividend and amortization of preferred stock issuance costs     (1,303 )   (1,302 )   (3,802 )   (5,049 )
   
 
 
 
 
Adjusted (loss) income from continuing operations available to common stockholders   $ 3,349   $ (713 ) $ 10,942   $ 13,418  
   
 
 
 
 
Average number of common shares outstanding — diluted(3)     32,368     34,535     32,386     34,382  
   
 
 
 
 
Adjusted income (loss) from continuing operations available to common shareholders   $ 0.10   $ (0.02 ) $ 0.34   $ 0.39  
   
 
 
 
 
CASH FLOW HIGHLIGHTS                          
Operating cash flows before interest and taxes paid   $ 66,651   $ 42,886   $ 212,319   $ 183,964  
Interest and taxes paid     (41,401 )   (34,336 )   (105,444 )   (98,278 )
   
 
 
 
 
Operating cash flows     25,250     8,550     106,875     85,686  
Capital expenditures     (12,079 )   (16,747 )   (36,924 )   (34,709 )
Acquisitions, net of cash acquired and return of escrowed funds         (3,731 )   (68,597 )   (87,731 )
Proceeds from issuance of redeemable preferred stock, net of issuance costs             54,765      
Proceeds from sale of assets, net         7,123     3,300     110,551  
Proceeds from issuance of debt, net of issuance costs     4,077     2,857     59,642     356,648  
Payments on long-term debt     (23,334 )   (849 )   (110,260 )   (458,221 )
Cash used in other investing and financing activities     (293 )   1,913     1,266     8,485  
   
 
 
 
 
Net increase (decrease) in cash and cash equivalents   $ (6,379 ) $ (884 ) $ 10,067   $ (19,291 )
   
 
 
 
 
BALANCE SHEET HIGHLIGHTS (in millions)

  September 30,
2000

  September 30,
2001

Unrestricted cash and cash equivalents   $ 47.5   $ 28.2
   
 
Restricted cash and investments   $ 117.7   $ 122.4
   
 
Total long-term debt, including current maturities   $ 1,098.0   $ 1,006.4
   
 
Revolver availability, net   $ 90.4   $ 115.7
   
 

NOTES:

(1)
Adjustments consist of: (i) special charges, which are primarily related to severance, lease terminations and impairments of long-lived assets in the 2000 periods and losses on the sale of the Company's Canadian subsidiary in the 2001 period; and (ii) exclusion of the Tricare pricing settlements net of certain incurred claims adjustments in the 2001 period.

(2)
The tax provision has been adjusted to reflect application of a 40% tax rate to the sum of pre-tax income plus permanent tax differences which is consistent with Magellan's practice on ongoing operating income.

(3)
Conversion of the redeemable preferred stock was not presumed due to the antidilutive effect.



QuickLinks